Cytochrome P450 2C9 single nucleotide polymorphisms (SNPs) that are known to affect warfarin metabolism.
. | Prevalence (%) . | . | . | ||||
---|---|---|---|---|---|---|---|
Designation . | Asian . | White . | Black . | Protein Change . | SNP . | Effect on Warfarin Dose . | Sample References . |
† CYP2C9*1 is the wild-type allele. | |||||||
CYP2C9*1 † | 98.2 | 80.3 | 94.2 | none | none | referent | |
CYP2C9*2 | 0 | 12.7 | 3.4 | Arg144Cys | C430T | −14% to −20% | 26,39–42 |
CYP2C9*3 | 1.8 | 7.0 | 1.5 | Ile359Leu | A1061C | −21% to −49% | 26,39–42 |
. | Prevalence (%) . | . | . | ||||
---|---|---|---|---|---|---|---|
Designation . | Asian . | White . | Black . | Protein Change . | SNP . | Effect on Warfarin Dose . | Sample References . |
† CYP2C9*1 is the wild-type allele. | |||||||
CYP2C9*1 † | 98.2 | 80.3 | 94.2 | none | none | referent | |
CYP2C9*2 | 0 | 12.7 | 3.4 | Arg144Cys | C430T | −14% to −20% | 26,39–42 |
CYP2C9*3 | 1.8 | 7.0 | 1.5 | Ile359Leu | A1061C | −21% to −49% | 26,39–42 |